OFIX
Orthofix Medical Inc. (OFIX) ESG Analysis Analysis (2026)
Overall Score
Environmental
No material environmental disclosures or sustainability metrics were provided this month.
Capital intensity remains manageable, with capex at 5.3% of revenue and capex/depreciation at 0.34x, suggesting limited near-term environmental reinvestment pressure.
Social
No material social or workforce-related disclosures or news were provided this month.
SG&A remains elevated at 50.3% of revenue, which may indicate ongoing operating complexity but is not a direct social disclosure.
Governance
No material governance disclosures or board/ownership updates were provided this month.
Balance-sheet leverage remains moderate, with net debt to EBITDA at 1.22x and a current ratio of 2.84x, supporting financial flexibility.
Risk
No material ESG-related controversies, regulatory actions, or litigation were reported this month.
Weak profitability and cash generation remain a concern, with negative ROA (-7.1%), ROE (-14.1%), and free cash flow yield (-6.5%).
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Orthofix Medical Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

